1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > EDAP TMS S.A. (EDAP) - Product Pipeline Analysis, 2015 Update

Summary

EDAP TMS S.A. (EDAP) is a medical device company. It carries out the development, production and distribution of minimally invasive medical devices for the treatment of urological diseases. The company offers its products and services through its two divisions: High Intensity Focused Ultrasound (HIFU)and Urology Devices and Services (UDS). Some of its products include Ablatherm HIFU minimally-invasive treatment for localized prostate cancerand Sonolith extracorporeal shock-wave lithotripters (ESWL). The company also offers mobile services for HIFU and lithotripters. Its products find applications in hospitals, urology clinics and research institutions. The sells its products through direct sales force and distributors in the US, France, Italy, Germany, Japan, South Korea, Malaysia and through representative office in UAE. The company operates through its subsidiaries located in Americas, Europe, Middle-East-Africa, Asia and Australia-New Zealand. EDAP is headquartered in Vaulx-en-Velin, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EDAP TMS S.A.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

EDAP TMS S.A. (EDAP) - Product Pipeline Analysis, 2015 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
EDAP TMS S.A. Company Snapshot 5
EDAP TMS S.A. Company Overview 5
Key Information 5
EDAP TMS S.A. Pipeline Products and Clinical Trials Overview 6
EDAP TMS S.A. - Pipeline Analysis Overview 8
Business Description 8
Key Facts 9
EDAP TMS S.A. - Major Products and Services 10
EDAP TMS S.A. Pipeline Products by Development Stage 11
EDAP TMS S.A. Pipeline Products Overview 12
Ablatherm HIFU Device - Prostate Cancer 12
Ablatherm HIFU Device - Prostate Cancer Product Overview 12
HIFU System - Liver Cancer 13
HIFU System - Liver Cancer Product Overview 13
HIFU Triggered Drug Delivery System 14
HIFU Triggered Drug Delivery System Product Overview 14
EDAP TMS S.A. - Key Competitors 15
EDAP TMS S.A. - Key Employees 16
EDAP TMS S.A. - Key Employee Biographies 17
EDAP TMS S.A. - Locations And Subsidiaries 18
Head Office 18
Other Locations and Subsidiaries 18
Recent Developments 19
EDAP TMS S.A., Recent Developments 19
Aug 26, 2015: EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015 19
Aug 25, 2015: EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter 20
Jul 21, 2015: EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU 20
Jul 14, 2015: EDAP Names Francois Dietsch Chief Financial Officer 20
Jul 07, 2015: EDAP's Focal One HIFU Device Adopted by Two University Hospitals in Switzerland 21
Jul 02, 2015: EDAP Announces Senior Management Transition 21
Jun 09, 2015: EDAP Announces Focal One HIFU Installation at Germany's Martini-Klinik 21
May 12, 2015: EDAP Reports First Quarter 2015 Results 22
Apr 01, 2015: EDAP Reports Fourth Quarter and Full Year 2014 Results 23
Mar 31, 2015: EDAP Announces Sale of First Focal One HIFU Device in North America 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
EDAP TMS S.A., Key Facts 5
EDAP TMS S.A. Pipeline Products and Clinical Trials Overview 6
EDAP TMS S.A. Pipeline Products by Equipment Type 6
EDAP TMS S.A. Pipeline Products by Indication 7
EDAP TMS S.A., Key Facts 9
EDAP TMS S.A., Major Products and Services 10
EDAP TMS S.A. Number of Pipeline Products by Development Stage 11
EDAP TMS S.A. Pipeline Products Summary by Development Stage 11
Ablatherm HIFU Device - Prostate Cancer - Product Status 12
Ablatherm HIFU Device - Prostate Cancer - Product Description 12
HIFU System - Liver Cancer - Product Status 13
HIFU System - Liver Cancer - Product Description 13
HIFU Triggered Drug Delivery System - Product Status 14
HIFU Triggered Drug Delivery System - Product Description 14
EDAP TMS S.A., Key Employees 16
EDAP TMS S.A., Key Employee Biographies 17
EDAP TMS S.A., Subsidiaries 18

List of Figures
EDAP TMS S.A. Pipeline Products by Equipment Type 7
EDAP TMS S.A. Pipeline Products by Development Stage 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H2 2016

Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Prostate Specific ...

Bone Metastasis - Pipeline Review, H2 2016

Bone Metastasis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Bone Metastasis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Pipeline Review, H2 2016, provides an overview of ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.